The Graft-Versus-Leukemia Effect in AML von Sweeney, Connor, Vyas, Paresh

Volltext

Disease Models & Mechanisms announces a new Editor-in-Chief von Vyas, Paresh

Volltext

An Overview of Targeted Therapies in Acute Myeloid Leukemia von Turkalj, Sven, Radtke, Felix A., Vyas, Paresh

Volltext

EGA for a Convective Regime Over a Vertical Cylinder Stretching Linearly von Vyas, Paresh, Yadav, Kusum

Volltext

A protocol for simultaneous high-sensitivity genotyping and chromatin accessibility profiling in single cells von Turkalj, Sven, Jakobsen, Niels Asger, Groom, Angus, Radtke, Felix A., Vyas, Paresh

Volltext

Entropy Analysis for boundary layer Micropolar fluid flow von Vyas, Paresh, Kumar Kasana, Rajesh, Khan, Sahanawaz

Volltext

Assessment of Minimal Residual Disease in Standard-Risk AML von Ivey, Adam, Hills, Robert K, Simpson, Michael A, Jovanovic, Jelena V, Gilkes, Amanda, Grech, Angela, Patel, Yashma, Bhudia, Neesa, Farah, Hassan, Mason, Joanne, Wall, Kerry, Akiki, Susanna, Griffiths, Michael, Solomon, Ellen, McCaughan, Frank, Linch, David C, Gale, Rosemary E, Vyas, Paresh, Freeman, Sylvie D, Russell, Nigel, Burnett, Alan K, Grimwade, David

Volltext

Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation von Hamlett, Isla, Draper, Julia, Strouboulis, John, Iborra, Francisco, Porcher, Catherine, Vyas, Paresh

Volltext

Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets von Vyas, Paresh, Ault, Kenneth, Jackson, Carl W., Orkin, Stuart H., Shivdasani, Ramesh A.

Volltext

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party von Schuurhuis, Gerrit J., Heuser, Michael, Freeman, Sylvie, Béné, Marie-Christine, Buccisano, Francesco, Cloos, Jacqueline, Grimwade, David, Haferlach, Torsten, Hills, Robert K., Hourigan, Christopher S., Jorgensen, Jeffrey L., Kern, Wolfgang, Lacombe, Francis, Maurillo, Luca, Preudhomme, Claude, van der Reijden, Bert A., Thiede, Christian, Venditti, Adriano, Vyas, Paresh, Wood, Brent L., Walter, Roland B., Döhner, Konstanze, Roboz, Gail J., Ossenkoppele, Gert J.

Volltext

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response von Amatangelo, Michael D., Quek, Lynn, Shih, Alan, Stein, Eytan M., Roshal, Mikhail, David, Muriel D., Marteyn, Benoit, Farnoud, Noushin Rahnamay, de Botton, Stephane, Bernard, Olivier A., Wu, Bin, Yen, Katharine E., Tallman, Martin S., Papaemmanuil, Elli, Penard-Lacronique, Virginie, Thakurta, Anjan, Vyas, Paresh, Levine, Ross L.

Volltext

Transient abnormal myelopoiesis without constitutional Down syndrome von Igne Kairiene, Vaidas Dirse, Ugnius Mickys, Audrone Muleviciene, Paresh Vyas, Jelena Rascon

Volltext

The impact of trisomy 21 on early human hematopoiesis von Roy, Anindita, Cowan, Gillian, Vyas, Paresh, Roberts, Irene

Volltext

New directions for emerging therapies in acute myeloid leukemia: the next chapter von Daver, Naval, Wei, Andrew H., Pollyea, Daniel A., Fathi, Amir T., Vyas, Paresh, DiNardo, Courtney D.

Volltext

Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells von Karamitros, Dimitris, Stoilova, Bilyana, Aboukhalil, Zahra, Hamey, Fiona, Reinisch, Andreas, Samitsch, Marina, Quek, Lynn, Otto, Georg, Repapi, Emmanouela, Doondeea, Jessica, Usukhbayar, Batchimeg, Calvo, Julien, Taylor, Stephen, Goardon, Nicolas, Six, Emmanuelle, Pflumio, Francoise, Porcher, Catherine, Majeti, Ravindra, Göttgens, Berthold, Vyas, Paresh

Volltext

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia von Stein, Eytan M., DiNardo, Courtney D., Pollyea, Daniel A., Fathi, Amir T., Roboz, Gail J., Altman, Jessica K., Stone, Richard M., DeAngelo, Daniel J., Levine, Ross L., Flinn, Ian W., Kantarjian, Hagop M., Collins, Robert, Patel, Manish R., Frankel, Arthur E., Stein, Anthony, Sekeres, Mikkael A., Swords, Ronan T., Medeiros, Bruno C., Willekens, Christophe, Vyas, Paresh, Tosolini, Alessandra, Xu, Qiang, Knight, Robert D., Yen, Katharine E., Agresta, Sam, de Botton, Stephane, Tallman, Martin S.

Volltext

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment von Mussai, Francis, De Santo, Carmela, Abu-Dayyeh, Issa, Booth, Sarah, Quek, Lynn, McEwen-Smith, Rosanna M., Qureshi, Amrana, Dazzi, Francesco, Vyas, Paresh, Cerundolo, Vincenzo

Volltext

Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia von Giustacchini, Alice, Thongjuea, Supat, Barkas, Nikolaos, Woll, Petter S, Povinelli, Benjamin J, Booth, Christopher A G, Sopp, Paul, Norfo, Ruggiero, Rodriguez-Meira, Alba, Ashley, Neil, Jamieson, Lauren, Vyas, Paresh, Anderson, Kristina, Segerstolpe, Åsa, Qian, Hong, Olsson-Strömberg, Ulla, Mustjoki, Satu, Sandberg, Rickard, Jacobsen, Sten Eirik W, Mead, Adam J

Volltext

The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis von Muskens, Ivo S., Li, Shaobo, Jackson, Thomas, Elliot, Natalina, Hansen, Helen M., Myint, Swe Swe, Pandey, Priyatama, Schraw, Jeremy M., Roy, Ritu, Anguiano, Joaquin, Goudevenou, Katerina, Siegmund, Kimberly D., Lupo, Philip J., de Bruijn, Marella F. T. R., Walsh, Kyle M., Vyas, Paresh, Ma, Xiaomei, Roy, Anindita, Roberts, Irene, Wiemels, Joseph L., de Smith, Adam J.

Volltext

DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation von Godfrey, Laura, Crump, Nicholas T., Thorne, Ross, Lau, I-Jun, Repapi, Emmanouela, Dimou, Dimitra, Smith, Alastair L., Harman, Joe R., Telenius, Jelena M., Oudelaar, A. Marieke, Downes, Damien J., Vyas, Paresh, Hughes, Jim R., Milne, Thomas A.

Volltext